OXTRIPHYLLINE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for oxtriphylline and what is the scope of freedom to operate?
Oxtriphylline
is the generic ingredient in four branded drugs marketed by Parke Davis, Morton Grove, Watson Labs, and Warner Chilcott Llc, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.There are three drug master file entries for oxtriphylline.
Summary for OXTRIPHYLLINE
US Patents: | 0 |
Tradenames: | 4 |
Applicants: | 4 |
NDAs: | 7 |
Drug Master File Entries: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 37 |
Patent Applications: | 5,057 |
DailyMed Link: | OXTRIPHYLLINE at DailyMed |
US Patents and Regulatory Information for OXTRIPHYLLINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Morton Grove | OXTRIPHYLLINE PEDIATRIC | oxtriphylline | SYRUP;ORAL | 088242-001 | Dec 5, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Warner Chilcott Llc | CHOLEDYL SA | oxtriphylline | TABLET, EXTENDED RELEASE;ORAL | 087863-001 | May 24, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Parke Davis | CHOLEDYL | oxtriphylline | TABLET, DELAYED RELEASE;ORAL | 009268-007 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |